Zsofia D. Drobni, MD, PhD

Cardiology fellow @semmelweishu | Alumni research fellow @MassGeneral @CIRC_MGH | #CVImaging & #Cardiooncology

[Zsofia D. Drobni, MD, PhD @zsofidrobni]

Engaging correspondence regarding our recent paper in @CircAHA on ICI and ⬆️🧡⚡️ events| https://t.co/PoEVKrOhd0 |Our response: https://t.co/1dhFUnw3Cb with @TomasNeilan @th_mayrhofer|Video ⬇️for catching up #CardioOnc #ImmunoOnc @CIRC_MGH @semmelweishu

[Ana Barac, MD, PhD, FACC, FAHA @AnaBaracCardio]

Which Cardiac Troponin do You use in a patient with suspected ICI Myocarditis? Great to share @InovaHealth approach in #JACCCardioOnc @JACCJournals @ChrisDefilippi @RaymondWadlowMD @InovaSchar @ISHVnews https://t.co/FFIKk1yIfz

[European Society of Cardiology News @ESCardioNews]

Upgrade to cardiac resynchronisation therapy benefits #HeartFailure patients with pacing https://t.co/hJR9r4CxJy

#ESCCongress @DrMerkely

[JAMA @JAMA_current]

Among study participants with lymphoma who were being treated with anthracyclines, prophylactic use of atorvastatin over 12 months was associated with a lower rate of cardiac systolic dysfunction. https://t.co/JZVqaltrYA

[Semmelweis University @semmelweishu]

Dr. Scott David Solomon, the world-renowned cardiologist of Harvard Medical School received the university’s most prestigious international scientific recognition, the Semmelweis Budapest Award. Heartfelt congratulations to Professor Solomon!
Read more:
https://t.co/mXLRkdu5zB

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer https://t.co/Y05e9jkrCr @zsofidrobni @TomasNeilan

[Pál Maurovich-Horvat @PalMaurovich]

https://t.co/tuxKO1sIMk

#XPECTMI

[Pál Maurovich-Horvat @PalMaurovich]

Should post STEMI PCI pathway include routine #FFRCT for assessing flow impairment of non culprit lesions? 🫀Thought provoking #XPECTMI study suggests #YesCCT at index event can predict future invasive FFR‼️
Fantastic work by @semmelweishu researchers! Congrats!

[Tomas G. Neilan, MD, MPH @TomasNeilan]

Congrats @husam247 and @dineshpmcc1. Definitely enough now to think of a RCT. If only the SGLT2i companies were interested…

[Tomas G. Neilan, MD, MPH @TomasNeilan]

Fabulous work by @zsofidrobni from @semmelweishu and @CIRC_MGH on atherosclerosis with immune therapy. Thank you Dr. Ky for your leadership and your interest in this work. #ACC2023 #cardioonc

[Giselle A. Suero Abreu, MD PhD @GiselleSA_MDPhD]

Grateful for this amazing #CardioOnc team 🫀💉💊 with ⁦⁦@zsofidrobni⁩ led by the ⁦@TomasNeilan⁩ ⁦@CIRC_MGH⁩ ⁦@MGHHeartHealth⁩. ⁩

[Zsofia D. Drobni, MD, PhD @zsofidrobni]

@jmcchiefs @ibolya_csecs @BidmcCvi @MayoClinicCV Congrats Ibi!!! 🥳

[Jacobi Internal Medicine Chiefs @jmcchiefs]

Ibolya is a fantastic medical educator and recipient of @EinsteinMed Davidoff Society Teaching star award. 🌟

She is a team player, and an incredible source of support to her co-residents and interns. Thank you Ibi!! #JacobiStrong #MedTwitter #IMG #CardioTwitter

[Tomas G. Neilan, MD, MPH @TomasNeilan]

From @jaccjournals, over 30% of cancer patients are eligible for an ICI. A review on the potential for ICI related atherosclerosis - JACC: CardioOncology led by the amazing @GiselleSA_MDPhD from @MGHHeartHealth and @MGHCVFellows https://t.co/EuuxbMZQkU

[Zsofia D. Drobni, MD, PhD @zsofidrobni]

@oncology_cardio @ICOSociety @CCardiacON @TeresaLpezFdez1 @bogda_koczwara @drtarsh @MariaSolAndres1 @sdent_duke @TomasNeilan Congrats Sebastian!

[Zsofia D. Drobni, MD, PhD @zsofidrobni]

@ProfDewey @semmelweishu @DrMerkely @team_dewey @ChariteBerlin Congrats!!! 🥳

[Tomas G. Neilan, MD, MPH @TomasNeilan]

Sodium-glucose cotransporter-2 inhibitors and heart failure and mortality in patients with cancer https://t.co/j9R3QdMo5G
In a large mostly non-anthracycline cancer population, SGLT2i use was associated with lower incident HF and prolonged overall survival

[Zsofia D. Drobni, MD, PhD @zsofidrobni]

#DISCHARGE

[Richard Ferraro @RichardAFerraro]

Really privileged to contribute to this work led by Dr. Trost and many other mentors @hopkinsheart

Cardiac imaging is a hugely exciting place to be right now, stay tuned!

https://t.co/TEfK0ZXGPd

[Marshall Long @OGBTC]

Some real life stuff here.
"Success isn't linear" by Yoann Bourgeois

[Stephen V Liu, MD @StephenVLiu]

Be sure to read the latest ESMO Clinical Practice Guideline @Annals_Oncology for multi-disciplinary guidance on toxicities from cancer immunotherapy. @myESMO

https://t.co/JOHG5zmsCa

[Zsofia D. Drobni, MD, PhD @zsofidrobni]

Great summary of the #DISCHARGE trial results by @ProfDewey at the Hungarian CV Imaging Meeting! 💁🏻‍♀️ Stay tuned for the results from the next analysis! 👱‍♂️🫀👩‍🦳 @PalMaurovich @team_dewey @semmelweishu #CardiacCT #chestpain